Crawford Lake Capital Management, LLC Sarepta Therapeutics, Inc. Transaction History

Crawford Lake Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $1.69 Million - $2.7 Million	-20,511 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $1.57 Million - $2.78 Million	20,511 New	20,511 $2.65 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $5.35 Million - $7.5 Million	-46,415 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $3.33 Million - $7.13 Million	46,415 New	46,415 $6.14 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.